Research demonstrates male birth control pill is ready for human trials
March 28, 2025
Newly published research from Dr. Gunda Georg and the University of Minnesota College of Pharmacy lays the foundation for a hormone-free male birth control pill to enter human clinical trials.
The research, published in Communications Medicine, showed that the oral contraceptive YCT-529 lowered sperm counts in under two weeks in male non-human primates, caused infertility in male mice with a 99% efficacy rate in pregnancy prevention, offered fully-recovered fertility after stopping the drug, and resulted in no detectable side effects.
Read the full research brief here.
Media Contacts
Related Stories
Following a partnership with the Minnesota Department of Health (MDH) that mapped pharmacy access gaps across the state, the University of Minnesota College of Pharmacy is digging deeper to understand the reason behind closures and impacts on community health.
YCT-529 continues to progress efficiently in clinical studies.
The new journal promises to be highly interdisciplinary and translational.